INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 104 filers reported holding INTERSECT ENT INC in Q4 2016. The put-call ratio across all filers is 112.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $782,000 | -12.8% | 20,876 | -8.6% | 0.18% | -4.2% |
| Q1 2018 | $897,000 | +21.2% | 22,833 | -0.0% | 0.19% | +31.9% |
| Q4 2017 | $740,000 | +4.1% | 22,840 | +0.1% | 0.14% | +38.5% |
| Q3 2017 | $711,000 | -61.6% | 22,821 | -65.5% | 0.10% | -52.7% |
| Q2 2017 | $1,850,000 | +4.3% | 66,199 | -36.0% | 0.22% | +26.4% |
| Q1 2017 | $1,773,000 | +25.4% | 103,397 | -11.5% | 0.17% | +47.5% |
| Q4 2016 | $1,414,000 | -20.2% | 116,860 | +4.4% | 0.12% | -30.2% |
| Q3 2016 | $1,773,000 | +48.1% | 111,915 | +20.9% | 0.17% | +2.4% |
| Q2 2016 | $1,197,000 | +59.6% | 92,541 | +134.3% | 0.16% | +60.2% |
| Q1 2016 | $750,000 | -43.3% | 39,492 | -32.8% | 0.10% | -38.7% |
| Q4 2015 | $1,323,000 | -32.4% | 58,788 | -29.8% | 0.17% | -45.6% |
| Q3 2015 | $1,958,000 | +88.6% | 83,690 | +130.9% | 0.31% | +81.8% |
| Q2 2015 | $1,038,000 | +322.0% | 36,246 | +172.9% | 0.17% | +385.7% |
| Q4 2014 | $246,000 | – | 13,280 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |